Exforge and Tamsulosin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Exforge (amlodipine besylate; valsartan) and Tamsulosin (tamsulosin). Common drug interactions include fatigue among females and pain among males.

The phase IV clinical study analyzes what interactions people have when they take Exforge and Tamsulosin. It is created by eHealthMe based on reports of 90 people who take the same drugs from the FDA, and is updated regularly.

What is Exforge?

Exforge has active ingredients of amlodipine besylate; valsartan. It is often used in high blood pressure. eHealthMe is studying from 13,350 Exforge users. Check the latest studies of Exforge.

What is Tamsulosin?

Tamsulosin has active ingredients of tamsulosin. It is often used in prostate examination abnormal. eHealthMe is studying from 72,635 Tamsulosin users. Check the latest studies of Tamsulosin.



On Jul, 19, 2026

90 people who take Exforge and Tamsulosin together, and have interactions are studied.

Exforge and Tamsulosin drug interactions.

What are the common drug interactions of Exforge and Tamsulosin, by gender? *:

female:

  1. Fatigue (feeling of tiredness)
  2. Pain
  3. Pain in extremity
  4. Thyroidectomy

male:

  1. Pain
  2. Chronic kidney disease
  3. Arthralgia (joint pain)
  4. Injection site pain
  5. Nausea (feeling of having an urge to vomit)
  6. Prostate infection
  7. Infusion site pain
  8. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  9. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  10. Myalgia (muscle pain)

What are the common drug interactions of Exforge and Tamsulosin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Back pain
  2. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  3. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  4. Epistaxis (bleed from the nose)
  5. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  6. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
  7. Renal haemorrhage (bleeding from kidney)
  8. Respiratory failure (inadequate gas exchange by the respiratory system)

40-49:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Renal injury (kidney injury)

50-59:

  1. Ischaemia (insufficient supply of blood to an organ, usually due to a blocked artery)
  2. Migraine (headache)
  3. Nephrogenic anaemia (anaemia due to kidney disease)
  4. Neuralgia (pain in one or more nerves)
  5. Pain
  6. Pain in extremity
  7. Perirenal haematoma (haemorrhage from the kidney into the perirenal space)
  8. Pityriasis (a skin disease characterized by the shedding of fine flaky scales)
  9. Renal transplant
  10. Seborrhoeic dermatitis (a common, inflammatory skin condition that causes flaky, white to yellowish scales to form on oily areas such as the scalp)

60+:

  1. Pain
  2. Arthralgia (joint pain)
  3. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  4. Myalgia (muscle pain)
  5. Weight fluctuation
  6. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  7. Renal failure (kidney dysfunction)
  8. Type 2 diabetes mellitus
  9. Urine output decreased
  10. Vomiting

What are the existing conditions these people have? *

  1. High Blood Pressure: 22 people, 24.44%
  2. Pain: 11 people, 12.22%
  3. High Blood Cholesterol: 11 people, 12.22%
  4. Immunodeficiency Common Variable: 10 people, 11.11%
  5. Stress And Anxiety: 9 people, 10.00%
  6. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 9 people, 10.00%
  7. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 8.89%
  8. Diabetes: 7 people, 7.78%
  9. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 6 people, 6.67%
  10. Type 2 Diabetes: 5 people, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Exforge and Tamsulosin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Exforge and Tamsulosin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Exforge:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Tamsulosin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Exforge and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tamsulosin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on amlodipine besylate; valsartan and tamsulosin (the active ingredients of Exforge and Tamsulosin, respectively), and Exforge and Tamsulosin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: